Medexus Engages Adelaide Capital for Investor Relations Services and Reports Annual Meeting Results
TORONTO and CHICAGO and MONTREAL, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) is pleased to announce that it has entered into a consulting agreement (the “Consulting Agreement”) …